Welcome: this page shows keynote speakers for the National Academic GP Training Conference scheduled for 31 March and 1 April 2022
Dr Stephen Barclay
Title: Developing a clinical academic career: challenges, opportunities and working with PPI colleagues in Palliative Care
Stephen Barclay works clinically in General Practice and hospice Honorary Consultant. He is Associate Professor at Cambridge and Honorary Professor at the University of East Anglia. He leads the Cambridge Palliative and End of Life Care Group (PELiCam) and the teaching of Palliative Care in the Cambridge School of Clinical Medicine.
He is Clinical Lead for Palliative and End of Life Care for the Cambridge and Peterborough Integrated Care System and is Clinical Lead for the NHS East of England Strategic Clinical Network for PEOLC.
Dr Luke Allen
Title: Global Health Policy
Luke is a primary health care consultant to the WHO and World Bank. He completed his GP ACF in Oxford and continues to work as a part-time GP in the city. He holds a clinical research fellowship at London School of Hygiene and Tropical Medicine; sits on the RCGP Thames Valley Faculty board; and is a board member at the British Journal of General Practice. He led on many of the supporting documents for the WHO/UNICEF Declaration of Astana and has worked closely with senior health system leaders across low-, middle-, and high-income countries. He co-led the 2019 G7 report on primary health care.
Luke trained in medicine and international health at Bristol and completed his MPH in Global Health at Harvard. He has a postgraduate teaching certificate and is a Fellow of the Higher Education Academy. He has over 50 publications in the field of global health with research centring on primary care reform and the politics of population-level chronic disease prevention. He is the international lead for the Faculty of Public Health special interest group on integrating public health and primary care. He has spoken at two UN General Assembly health side events, and his work has been featured across multiple international media platforms including BBC News, the New Scientist, China Global TV, and the Wall Street Journal.
Professor Rebecca Fitzgerald & Dr Oliver Stovin
Title: This keynote session will focus on the Cytosponge (BEST3 Trial)
Biography: Dr Stovin
Oliver Stovin was a full time GP in Oundle from 1988-2015 with long term involvement with local organisations, local education and delivery of out of hours services. He was the Macmillan GP and Joint Cancer Lead for Cambridge and Peterborough CCG 2014-2021 and Macmillan GPAA 2018-2021. He is now retired but has continued his involvement with the Cytosponge project on a voluntary basis.
Following the BEST3 trial, he was an expert commentator for the NICE appraisal of Cytosponge, due to his work trying to implement delivery in primary care across Cambridgeshire just as the coronavirus pandemic began.
Biography: Professor Fitzgerald
Rebecca Fitzgerald is Professor of Cancer Prevention and Interim Director at the MRC Cancer Unit, University of Cambridge. She leads the Early Detection Programme of the CRUK Cambridge Centre which is part of the International Alliance in Early Detection (ACED) and practices medicine as Hon. Consultant in Gastroenterology and Oncology at Addenbrooke’s Hospital. The focus of her research group is to investigate the steps in malignant transformation in the oesophagus and stomach and to use this information to improve clinical early detection strategies.
Her work to develop and implement the Cytosponge and related biomarker assays for detection of Barrett’s oesophagus and associated dysplasia has been awarded a number of prizes including the Westminster Medal, the BMJ Gastro team of the year, an NHS Innovation prize, the CRUK Jane Wardle Early Detection Prize and recently the Don Listwin prize. In 2013, she was elected as a Fellow of the Academy of Medical Sciences and in 2021 elected a Member of EMBO. Rebecca is committed to teaching and is a Fellow of Medical Sciences at Trinity College Cambridge.